These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21886053)

  • 1. A paradigm shift in the outpatient approach to liver function tests.
    Senadhi V
    South Med J; 2011 Jul; 104(7):521-5. PubMed ID: 21886053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic liver diseases in patients with chronic kidney disease].
    Hrstić I; Ostojić R
    Acta Med Croatica; 2011; 65(4):349-53. PubMed ID: 22359907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
    Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
    J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, aetiology and associated co-morbidities of elevated aminotransferases in a german cohort of orthopaedic surgery patients.
    Lobstein S; Kaiser T; Liebert U; Wojan M; Leichtle A; Mössner J; Wiegand J; Tillmann HL
    Z Gastroenterol; 2008 May; 46(5):415-20. PubMed ID: 18461515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The natural course of hepatitis B and hepatitis C virus infection].
    Schwabe RF; Stremmel W
    Praxis (Bern 1994); 1998 Oct; 87(42):1403-7. PubMed ID: 9824947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBV-carriers: When is monitoring and surveillance sufficient? (point of view).
    Andreani T
    Clin Res Hepatol Gastroenterol; 2011 Dec; 35(12):813-8. PubMed ID: 21821479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
    Dohmen K; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2003; 50(54):2022-7. PubMed ID: 14696457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of chronic hepatitis in children with cancer.
    Sevinir B; Meral A; Günay U; Ozkan T; Ozuysal S; Sinirtas M
    Med Pediatr Oncol; 2003 Feb; 40(2):104-10. PubMed ID: 12461794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The burden and recent epidemiological changes of the main chronic liver diseases in a Greek referral tertiary centre.
    Giannousis IP; Papatheodoridis GV; Deutsch MJ; Manolakopoulos SG; Manesis EK; Koskinas JS; Archimandritis AJ
    Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):172-9. PubMed ID: 19738477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Budget impact analysis on the introduction of a guideline based hepatitis B and C screening into a routine check-up in the German primary care setting.
    Barth C; Neusser S; Biermann J; Wasem J; Berg T; Wiegand J; Wolffram I; Petroff D; Aidelsburger P; Grünbauer A; Neumann A
    Scand J Gastroenterol; 2018 Jan; 53(1):76-82. PubMed ID: 29065740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
    Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D
    Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differential chronic hepatitis diagnosis].
    Hinterberger W
    Wien Med Wochenschr; 2000; 150(23-24):476-80. PubMed ID: 11205178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. China's efforts to shed its title of "Leader in liver disease".
    Li X; Xu WF
    Drug Discov Ther; 2007 Oct; 1(2):84-5. PubMed ID: 22504391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferons in the management of viral hepatitis.
    Zein NN
    Cytokines Cell Mol Ther; 1998 Dec; 4(4):229-41. PubMed ID: 10068057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of alcohol on viral hepatitis and other forms of liver dysfunction.
    Balasubramanian S; Kowdley KV
    Clin Liver Dis; 2005 Feb; 9(1):83-101. PubMed ID: 15763231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The natural course of chronic HBV+HCV infection in children].
    Strokova TV; Machulan IV; Sentsova TB; Tumanova EL; Kaganov BS
    Eksp Klin Gastroenterol; 2013; (1):29-33. PubMed ID: 23951895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the treatment of hepatitis C.
    Lawrence SP
    Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of patients with HCC who are negative for both HBV and HCV markers.
    Watabe H; Shiratori Y; Tateishi R; Fujishima T; Akamatsu M; Koike Y; Obi S; Hamamura K; Sato S; Teratani T; Shiina S; Omata M
    Hepatogastroenterology; 2003; 50(54):2157-60. PubMed ID: 14696486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of significant liver fibrosis and cirrhosis in chronic hepatitis B patients with normal ALT in central Europe.
    Göbel T; Erhardt A; Herwig M; Poremba C; Baldus SE; Sagir A; Heinzel-Pleines U; Häussinger D
    J Med Virol; 2011 Jun; 83(6):968-73. PubMed ID: 21503908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monitoring patients with chronic hepatitis during and after therapy].
    Colić-Cvrlje V; Mise S
    Acta Med Croatica; 2009 Dec; 63(5):377-83. PubMed ID: 20198895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.